HCCBP1MAG-58K
MILLIPLEX® Human Circulating Cancer Biomarker Magnetic Bead Panel - Cancer Multiplex Assay
Circulating Cancer Biomarker Bead-Based Multiplex Assays using the Luminex technology enables the simultaneous analysis of multiple oncology biomarkers in various tumor types in human serum, plasma and cell culture samples.
別名:
human cancer biomarker immunoassay panel, luminex human circulating cancer biomarkers multiplex assay, millipore human circulating cancer biomarkers multiplex kit
About This Item
おすすめの製品
品質水準
化学種の反応性
human
メーカー/製品名
Milliplex®
assay range
accuracy: 35-108%
standard curve range: 0.09-67 mU/mL
(β-HCG)
standard curve range: 0.7-500 pg/mL
(IL-6)
standard curve range: 1.3-1000 pg/mL
(IL-8, TNFα)
standard curve range: 2.7-2000 pg/mL
(TRAIL, TGF-α)
standard curve range: 6.9-5000 pg/mL
(SCF)
テクニック
multiplexing: suitable
検出方法
fluorometric (Luminex xMAP)
輸送温度
wet ice
詳細
MILLIPLEX® Circulating Cancer Biomarker Panel 1 is a 25-plex kit that can be used for the simultaneous quantification of any or all of the following analytes in serum, plasma and tissue/cell lysate and culture supernatant samples: AFP, CA125, CA15-3, CA19-9, CEA, CYFRA21-1, sFas, sFasL, FGF2, β-HCG, HE4, HGF, IL-6, IL-8, Leptin, MIF, Osteopontin, Prolactin, PSA (free), PSA (total), SCF, TGFα, TNFα, TRAIL and VEGF. Note that certain biomarkers are tumor specific, such as PSA, while others, such as IL-8, have been detected in many cancers. PSA (free) and PSA (total) cannot be plexed together. This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.
The Luminex® xMAP® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.
Panel Type: Circulating Cancer
特異性
Cross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.
アプリケーション
- Analytes: α-Fetoprotein (AFP), CA125, CA15-3, CA19-9, CEA, CYFRA21-1, sFas (TNFRSF6), sFasL, FGF-2 (FGF-basic), β-HCG (HCGβ), HE4, HGF, IL-6, IL-8 (CXCL8), Leptin, MIF, Osteopontin (OPN), Prolactin, PSA (free)*, PSA (total)*, SCF, TGFα, TNFα, TRAIL (TNFSF10), VEGF.
- Note: Total PSA and Free PSA cannot be plexed together
- Recommended Sample Type: Human serum, plasma or tissue/cell culture supernatants or lysates
- Recommended Sample Dilution: 25 μL per well of 1:6 diluted plasma or serum, or 25 μL cell culture psaesaa sample undiluted or diluted in appropriate control medium
- Assay Run Time: Overnight (16-18 hr) at 2-8°C
- Research Category: Cancer
特徴および利点
包装
構成
Human Circulating Cancer Biomarker Panel 1 Quality Controls 1 and 2 (HCC-6058)
Serum Matrix (HCP-SM)
Note: Contains 0.08% Sodium Azide
Set of one 96-Well Plate with 2 Sealers (MAG-PLATE)
Assay Buffer (L-AB)
Note: Contains 0.08% Sodium Azide
10X Wash Buffer (L-WB)
Note: Contains 0.05% Proclin
Human Circulating Cancer Biomarker Panel 1 Detection Antibodies (HCC-1058 or HCC-1058-2)
Streptavidin-Phycoerythrin (L-SAPE 4)
Bead Diluent (LBD-4)
保管および安定性
その他情報
法的情報
免責事項
シグナルワード
Danger
危険有害性の分類
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
ターゲットの組織
Respiratory Tract
保管分類コード
10 - Combustible liquids
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
HCCBP1MAG-58K-08:
HCCBP1MAG-58K-12:
HCCBP1MAG-58K-20:
HCCBP1MAG-58K-02:
HCCBP1MAG-58K-13:
HCCBP1MAG-58K-14:
HCCBP1MAG-58K-03:
HCCBP1MAG-58K-23:
HCCBP1MAG-58K-04:
HCCBP1MAG-58K-05:
HCCBP1MAG-58K-18:
HCCBP1MAG-58K-07:
HCCBP1MAG-58K-22:
HCCBP1MAG-58K-01:
HCCBP1MAG-58K-15:
HCCBP1MAG-58K-11:
HCCBP1MAG-58K-19:
HCCBP1MAG-58K-09:
HCCBP1MAG-58K:
HCCBP1MAG-58K-16:
HCCBP1MAG-58K-06:
HCCBP1MAG-58K-10:
HCCBP1MAG-58K-17:
HCCBP1MAG-58K-24:
HCCBP1MAG-58K-21:
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
関連コンテンツ
Detection of cancer biomarkers through multiplex cancer assays can accelerate studies of normal homeostasis and tumorigenic processes. See how MILLIPLEX® multiplex cancer assays are advancing various cancer research areas including lung cancer, breast cancer, and immuno-oncology research.
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)